Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry
Association of Cardiovascular Disease With Respiratory Disease
The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)